1. Adjuvant Chemotherapy Is Associated with Improved Survival after Esophagectomy without Induction Therapy for Node-Positive Adenocarcinoma 
Paul J. Speicher, MD, Brian R. Englum, MD, Asvin M. Ganapathi, MD, Michael S. Mulvihill, MD, Matthew G. Hartwig, MD, Mark W. Onaitis, MD, Thomas A. D’Amico, MD, Mark F. Berry, MD 
Journal of Thoracic Oncology 
Volume 10, Issue 1, Pages (January 2015)
DOI: /JTO
Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

2. FIGURE 1
Trends in the use of adjuvant chemotherapy after margin-negative, node-positive esophagectomy.
Journal of Thoracic Oncology  , DOI: ( /JTO )
Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

3. FIGURE 2
Kaplan–Meier survival curves for patients (A) treated with versus without adjuvant chemotherapy; and (B) treated with versus without adjuvant chemotherapy and excluding patients experiencing a postoperative complication (defined as an unplanned readmission or length of stay >20 days).
Journal of Thoracic Oncology  , DOI: ( /JTO )
Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

4. FIGURE 3
Kaplan–Meier survival curves for patients who experienced a postoperative complication but were rescued to receive intended adjuvant chemotherapy compared to patients who (A) received adjuvant chemotherapy in the absence of complications; and (B) patients who did not experience complications or get adjuvant therapy.
Journal of Thoracic Oncology  , DOI: ( /JTO )
Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions